Pulmonary Emphysema Clinical Trial
Official title:
Unilateral vs. Bilateral IBV Placement
Patients with bilateral heterogeneous pulmonary emphysema benefit to differing degrees from unilateral ELVR with complete lobe closure in comparison with incomplete bilateral treatment.
Patient enrolment and data acquisition is to be carried out on a prospective basis. It is planned to enrol a total of 20 patients with bilateral heterogeneous pulmonary emphysema. All patients will undergo treatment at one study centre in Heidelberg. Patients will be considered for both unilateral and bilateral treatment with intrabronchial valves (IBV) on the basis of their emphysema distribution. Patients will be randomised to two treatment arms. 10 patients receive unilateral or bilateral treatment in each case. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
| Completed |
NCT00123422 -
Innovation in Pulmonary Rehabilitation
|
N/A | |
| Recruiting |
NCT02879331 -
Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils
|
N/A | |
| Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
| Completed |
NCT01051258 -
AeriSeal System for Lung Volume Reduction
|
Phase 1/Phase 2 | |
| Completed |
NCT00680056 -
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
|
Phase 4 | |
| Completed |
NCT01872624 -
Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
|
N/A | |
| Completed |
NCT01110252 -
Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
|
N/A | |
| Completed |
NCT00517998 -
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 | |
| Terminated |
NCT00205920 -
Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
|
Phase 2 | |
| Withdrawn |
NCT01849159 -
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
|
Phase 1/Phase 2 | |
| Completed |
NCT01869205 -
The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
|
Phase 3 | |
| Terminated |
NCT01320566 -
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
|
Phase 2/Phase 3 | |
| Completed |
NCT00683722 -
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
| Active, not recruiting |
NCT04465461 -
Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion
|
N/A | |
| Completed |
NCT04012359 -
Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax
|
||
| Recruiting |
NCT04918706 -
Allogeneic MSC Treatment for Pulmonary Emphysema
|
Phase 2 | |
| Terminated |
NCT01449292 -
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
|
Phase 3 | |
| Completed |
NCT00347659 -
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 | |
| Recruiting |
NCT02827721 -
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|